oprah winfrey glp 1 special Oprah's GLP-1 Special: The 12‑Month Stop, 20‑Lb Regain, and a Shift to Lifelong Medication Watch 'An Oprah Special: Shame,

International Journal of Food Sciences and Nutrition, 65(2), 245-250

While the absolute risk increase was modest, our findings point to an important potential adverse effect that clinicians should consider, especially in patients with predisposing factors for GERD

Excited to share my recent certification in () through GxP training

GLP-1 weight loss and diabetes medications, like Ozempic and Mounjaro, have been in use for nearly 20 years, but research is far from over

Customers who have certain health conditions may now be eligible to make purchases of these products using their HSA/FSA funds

As of early 2026, several potent single, dual, and triple incretin receptor agonists are in Phase 2/3 trials for MASH including : Survodutide : A dual glucagon (GCGR)/GLP-1 receptor agonist that has shown significant MASH resolution in Phase 2 trials